chevron_leftBack
As of 8 June 2026, IDT Australia Ltd. has a market cap of $12.2M USD, ranking #40199 globally and #1266 in Australia.
It ranks #3585 in the Healthcare sector, and #1169 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$12.2MUSD
17.1M AUD
Enterprise Value
$16.15MUSD
22.93M AUD
Revenue (TTM)
$13.56MUSD
19.0M AUD
EBITDA (TTM)
-$3.01MUSD
-4.27M AUD
Net Income (TTM)
-$4.37MUSD
-6.13M AUD
EBITDA Margin
-22%
Profit Margin
-32%
PS Ratio
0.9
PB Ratio
0.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Paul McDonald
open_in_new
Employees
100
Founded
1975
Website
en.idtaus.com.au
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | -2.7% | -9.1% | -20% | -32% | -64% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
IDT
IDT Australia Ltd
ISIN: AU000000IDT0
Shares Out.:
Shares Outstanding:
421.826M1
Shares Float:
347.578M2
|
0.0400 AUD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About IDT Australia Ltd.
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the United States. The company offers microbiological and analytical testing, clinical packaging, and pharmacy services. It also provides medicinal cannabis and psychedelics; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms. In addition, the company offers mRNA and antibody drug conjugates. Further, the company provides contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
ASX: SIG
|
$22.82B
187K%
31.98B AUD
|
52.3
|
|
ASX: PYC
|
$926.22M
7K%
1.3B AUD
|
-
|
|
ASX: RAC
|
$346.24M
3K%
485.18M AUD
|
-
|
|
ASX: CUV
|
$335.4M
3K%
469.99M AUD
|
14.5
|
|
ASX: SPL
|
$216.39M
2K%
303.23M AUD
|
-
|
|
ASX: MYX
|
$166.4M
1K%
233.18M AUD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
6M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
4M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
3M%
|
97.4
|
|
SIX: RO
|
$324.68B
3M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.43B
2M%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$277.35B
2M%
218.9B CHF
|
20.5
|
chevron_leftBack